ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    Donor Plasma Mitochondrial DNA Predicts Post-Transplant Renal Allograft Outcomes

    F. Han,1 S. Wan,2 N. Chen,2 L. Zheng,3 N. Zhang,4 Q. Sun,1 H. Li,1 Z. Huang,1 L. Hong,1 Q. Sun.1

    1Kidney Transplantation, Sun Yat-sen University, Guangzhou, China; 2Laboratory of Cancer Biomarkers and Liquid Biopsy, Henan University, Henan, China; 3Department of Medical Statistics and Epidemiology, Sun Yat-sen University, Guangzhou, China; 4Department of Pathology, Sun Yat-sen University, Sun Yat-sen, China.

    The lack of an accurate biomarker makes it difficult to determine whether an organ is acceptable for transplantation. Mitochondrial DNA (mtDNA) correlates with tissue damage…
  • 2018 American Transplant Congress

    Effect of De Novo Use of Everolimus with Reduced Calcineurin Inhibitor versus Standard Mycophenolic Acid-Based Regimen on Wound Healing Events in Kidney Transplant Recipients from TRANSFORM Study

    M. Henry, F. Citterio, M. Kim, D. Kim, P. Bernhardt, A. Gupta, Y. Watarai.

    TRANSFORM Study Group, Novartis Pharma AG, Basel, Switzerland.

    Purpose: Anti-proliferative properties of mammalian target of rapamycin inhibitors (mTORi) may affect the wound healing process and there are some reservations about including mTORi into…
  • 2018 American Transplant Congress

    Long Term Outcomes of a Steroid Free, Low Dose Tacrolimus with Everolimus Regimen in Kidney Transplant

    Y. Kassis,1 S. Park,1 A. Shetty,1 J. Leventhal,1 V. Mas,2 L. Gallon.1

    1Comprehensive Transplant Center, Northwestern University, Chicago, IL; 2Department of Surgery, University of Virginia, Charlottesville, VA.

    Tacrolimus (Tac) is the most effective immunosuppressive agent to prevent acute allograft rejection. However, long-term transplant (Tx) outcomes are limited, at least in part, by…
  • 2018 American Transplant Congress

    Opting out and Offers of 'Alibis' for Potential Living Kidney Donors in the US

    R. Iskander,1 S. Kulkarni,2 C. Thiessen.2

    1McMaster University, Hamilton, ON, Canada; 2Yale University School of Medicine, New Haven, CT.

    Purpose: To delineate rates of and reasons for opting out of living kidney donation, to determine if and how transplant centers offer alibis, to assess…
  • 2018 American Transplant Congress

    The New Crescentic Incision: A Good Option for Donor Nephrectomy

    M. Haberal,1 M. Kirnap,1 A. Akdur,1 E. Ayvazoglu Soy,1 S. Yildirim,1 G. Moray,1 Z. Kayhan,2 A. Torgay.2

    1Transplantation, Baskent University, Ankara, Turkey; 2Anesthesiology, Baskent University, Ankara, Turkey.

    Introduction: Living kidney donation helps to avoid or reduce the time period of dialysis and time spent on waiting lists for patients requiring a new…
  • 2018 American Transplant Congress

    The Impact of Lymphocele Formation after Kidney Transplantation on De Novo Donor Specific Antibody Formation

    L. Lehner, A. Hohberger, F. Halleck, E. Schrezenmeier, K. Budde, O. Staeck, D. Khadzhynov.

    Dept. of Nephrology and Medical Intensive Care, Charité Universtitätsmedizin Berlin, Berlin, Germany.

    Introduction: Lymphocele formation is a common complication after kidney transplantation and has been linked to rejection episodes. However, long-term outcome data are scarce and the…
  • 2018 American Transplant Congress

    Prevalence, Risk Factors and Impact of BK Viremia on Kidney Transplantation: Single Center Experience

    W. Hassan, A. El-Husseini, B. Suleiman, K. Wang, M. Yaseen, A. Maibam, A. Karim, A. Hines, A. Castellanos, V. Cornea, X. Mei, R. Gedaly, T. Waid.

    Nephrology, University of Kentucky, Lexington, KY.

    Introduction: BK viremia (BKV) is an emerging problem in renal transplantation. The risk factors and the impact of BKV on renal allograft and patient survival…
  • 2018 American Transplant Congress

    Participation in Paid Work across the Transplant Trajectory from the Perspective of End-Stage-Kidney-Disease Patients

    K. Gaudet, M. Achille.

    Psychology, University of Montreal, Montreal, QC, Canada.

    Purpose: To explore end-stage-kidney-disease patients' experiences of labour participation, from the kidney failure diagnosis to the post-transplant recovery period.Methods: A qualitative research design was adopted.…
  • 2018 American Transplant Congress

    Effect of Conversion to CTLA4Ig Treatment on Tacrolimus-Induced Diabetic Rats

    J. Il,1 L. Jin,1 K. Luo,1 S. Lim,1 Y. Shin,1 E. Ko,1,2 B. Chung,1,2 C. Yang.1,2

    1Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea; 2Transplant Research Center, The Catholic University of Korea, Seoul, Republic of Korea.

    Background: The effect of conversion to cytotoxic T-lymphocyte-associated protein 4 immunoglobulin (CTLA4Ig) treatment on tacrolimus (TAC)-induced renal dysfunction is well known, but its effect on…
  • 2018 American Transplant Congress

    Cognitive Impairment and Graft Loss in Kidney Transplant Recipients

    A. Thomas,1 J. Ruck,1 A. Shaffer,1 C. Haugen,1 H. Ying,1 F. Warsame,1 N. Chu,1 M. Carlson,1 A. Gross,1 S. Norman,2 D. Segev,1 M. McAdams-DeMarco.1

    1JHU, Baltimore; 2University of Michigan, Ann Arbor.

    Cognitive impairment is common in end-stage renal disease patients and impedes adherence to complex treatment regimens. Given the complexities of post-transplant immunosuppression, we hypothesized that…
  • « Previous Page
  • 1
  • …
  • 252
  • 253
  • 254
  • 255
  • 256
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences